A call to action to harmonize patient-reported outcomes evidence requirements across key European HTA bodies in oncology.
Future Oncol
; 18(29): 3323-3334, 2022 Sep.
Article
em En
| MEDLINE
| ID: mdl-36053168
Patient-reported outcomes (PRO) are information provided directly by the person who is experiencing a disease or undergoing a treatment, without additional interpretation by a clinician or caregiver. Along with other outcome measures, PROs may be included in the body of evidence used by health technology assessment bodies in their review. In this article, the authors summarize the guidance documents published by key health technology assessment agencies and reviewed 20 past cancer drug case studies to understand how different agencies use PROs when deciding on recommendations for new cancer treatments.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Avaliação da Tecnologia Biomédica
/
Oncologia
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article